H. Lundbeck A/S: Hypotension trials

The registry lists 10 Hypotension studies with H. Lundbeck A/S as lead sponsor. 0 are open to participants now and 9 have results posted.

Phase 1 1Phase 2 2Phase 3 6Phase 4 1(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Sustained Effect of Droxidopa in Symptomatic Neurogenic Orthostatic HypotensionCompletedNCT02586623Phase 4Results posted
• A Clinical Study of Patients With Symptomatic NOH to Assess Sustained Effects of Droxidopa TherapyTerminatedNCT01927055Phase 3Results posted
• A Two Part Study (306A/306B) to Assess Droxidopa in Treatment of NOH in Patients With Parkinson's DiseaseCompletedNCT01176240Phase 3Results posted
• Clinical Study of Droxidopa in Patients With Neurogenic Orthostatic Hypotension (NOH) (Droxi-304)CompletedNCT01132326Phase 3Results posted
• Study To Assess The Clinical Benefit Of Droxidopa In Subjects With Chronic Fatigue SyndromeTerminatedNCT00977171Phase 2Results posted
• A Clinical Study for Patients With Neurogenic Orthostatic Hypotension (NOH) Using DroxidopaCompletedNCT00782340Phase 3Results posted
• Open-Label Clinical Study of Droxidopa in Patients With Neurogenic Orthostatic Hypotension (NOH)CompletedNCT00738062Phase 3Results posted
• Safety and Benefit Study of Droxidopa to Treat Patients With Intradialytic HypotensionCompletedNCT00657046Phase 2Results posted
• Clinical Study of Droxidopa in Patients With Neurogenic Orthostatic Hypotension (NOH)CompletedNCT00633880Phase 3Results posted
• Study of the Fed-Fast Pharmocokinetics and Bioequivalance of 300mg Capsules of DroxidopaCompletedNCT01149629Phase 1